LIGAND PHARMACEUTICALS INC (LGND) › EPS (Diluted)LIGAND PHARMACEUTICALS INC (LGND) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2011: $0.492012: $-0.032013: $0.552014: $0.562015: $10.832016: $-0.082017: $0.532018: $5.962019: $31.852020: $-0.182021: $3.312022: $-1.982023: $2.942024: $-0.222025: $6.13$6.132011EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$6.13+2886.4%2024$-0.22-107.5%2023$2.94+248.5%2022$-1.98-159.8%2021$3.31+1938.9%2020$-0.18-100.6%2019$31.85+434.4%2018$5.96+1024.5%2017$0.53+762.5%2016$-0.08-100.7%2015$10.83+1833.9%2014$0.56+1.8%2013$0.55+1933.3%2012$-0.03-106.1%2011$0.49—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share